HP011-101, HP828-101, and Standard Care for Pressure Ulcers

NCT01273428 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2012-09-12

No results posted yet for this study

Summary

Testing a drug and a device for the treatment of pressure ulcers, compared with current treatments.

Conditions

  • Pressure Ulcers

Interventions

DRUG

HP011-101

DEVICE

HP-828-101

OTHER

Standard Care

Sponsors & Collaborators

  • Healthpoint

    lead INDUSTRY

Principal Investigators

  • Herbert B Slade, MD · Healthpoint, Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2011-06-30
Completion
2011-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01273428 on ClinicalTrials.gov